CN111437234A - Baby hip protection cream - Google Patents
Baby hip protection cream Download PDFInfo
- Publication number
- CN111437234A CN111437234A CN202010404346.3A CN202010404346A CN111437234A CN 111437234 A CN111437234 A CN 111437234A CN 202010404346 A CN202010404346 A CN 202010404346A CN 111437234 A CN111437234 A CN 111437234A
- Authority
- CN
- China
- Prior art keywords
- extract
- shea butter
- olive oleate
- skin
- infant hip
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000006071 cream Substances 0.000 title claims abstract description 40
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 claims abstract description 28
- 235000018936 Vitellaria paradoxa Nutrition 0.000 claims abstract description 26
- 241001135917 Vitellaria paradoxa Species 0.000 claims abstract description 26
- 229940057910 shea butter Drugs 0.000 claims abstract description 26
- TXFPEBPIARQUIG-UHFFFAOYSA-N 4'-hydroxyacetophenone Chemical compound CC(=O)C1=CC=C(O)C=C1 TXFPEBPIARQUIG-UHFFFAOYSA-N 0.000 claims abstract description 24
- 240000007817 Olea europaea Species 0.000 claims abstract description 21
- 229940049964 oleate Drugs 0.000 claims abstract description 20
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims abstract description 20
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 claims abstract description 14
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 claims abstract description 14
- 229960000458 allantoin Drugs 0.000 claims abstract description 14
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 claims abstract description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 14
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 claims abstract description 13
- 229940036350 bisabolol Drugs 0.000 claims abstract description 13
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 claims abstract description 13
- 235000013871 bee wax Nutrition 0.000 claims abstract description 12
- 229920001285 xanthan gum Polymers 0.000 claims abstract description 12
- 239000000230 xanthan gum Substances 0.000 claims abstract description 12
- 229940082509 xanthan gum Drugs 0.000 claims abstract description 12
- 235000010493 xanthan gum Nutrition 0.000 claims abstract description 12
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 claims abstract description 11
- 229940002508 ginger extract Drugs 0.000 claims abstract description 11
- 235000020708 ginger extract Nutrition 0.000 claims abstract description 11
- 239000012166 beeswax Substances 0.000 claims abstract description 10
- 239000003995 emulsifying agent Substances 0.000 claims abstract description 8
- 230000008719 thickening Effects 0.000 claims abstract description 7
- 239000004164 Wax ester Substances 0.000 claims abstract description 6
- 230000002421 anti-septic effect Effects 0.000 claims abstract description 6
- 239000004519 grease Substances 0.000 claims abstract description 6
- 239000003381 stabilizer Substances 0.000 claims abstract description 6
- 235000019386 wax ester Nutrition 0.000 claims abstract description 6
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 claims abstract description 5
- 229920002498 Beta-glucan Polymers 0.000 claims abstract description 5
- UWJJYHHHVWZFEP-UHFFFAOYSA-N pentane-1,1-diol Chemical compound CCCCC(O)O UWJJYHHHVWZFEP-UHFFFAOYSA-N 0.000 claims abstract description 5
- 229940081733 cetearyl alcohol Drugs 0.000 claims abstract description 4
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 claims abstract description 4
- 235000021355 Stearic acid Nutrition 0.000 claims description 11
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 11
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 11
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims description 11
- 239000003755 preservative agent Substances 0.000 claims description 11
- 239000008117 stearic acid Substances 0.000 claims description 11
- SFFVATKALSIZGN-UHFFFAOYSA-N hexadecan-7-ol Chemical compound CCCCCCCCCC(O)CCCCCC SFFVATKALSIZGN-UHFFFAOYSA-N 0.000 claims description 10
- 229920002307 Dextran Polymers 0.000 claims description 7
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 claims description 7
- 229930003799 tocopherol Natural products 0.000 claims description 7
- 229960001295 tocopherol Drugs 0.000 claims description 7
- 239000011732 tocopherol Substances 0.000 claims description 7
- 235000010384 tocopherol Nutrition 0.000 claims description 7
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims description 7
- 230000002335 preservative effect Effects 0.000 claims description 6
- SGNBVLSWZMBQTH-FGAXOLDCSA-N Campesterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@H](C(C)C)C)C)CC4)CC3)CC=2)CC1 SGNBVLSWZMBQTH-FGAXOLDCSA-N 0.000 claims description 4
- BTEISVKTSQLKST-UHFFFAOYSA-N Haliclonasterol Natural products CC(C=CC(C)C(C)(C)C)C1CCC2C3=CC=C4CC(O)CCC4(C)C3CCC12C BTEISVKTSQLKST-UHFFFAOYSA-N 0.000 claims description 4
- SGNBVLSWZMBQTH-PODYLUTMSA-N campesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](C)C(C)C)[C@@]1(C)CC2 SGNBVLSWZMBQTH-PODYLUTMSA-N 0.000 claims description 4
- 235000000431 campesterol Nutrition 0.000 claims description 4
- NSNRBCFTRWSAAQ-BLPFIKBVSA-N C(CCCCCCCCCCCCCCC)[C@@]1(N(C[C@@H](C1)O)C(CCCCCCCCCCCCCCC)=O)C(=O)O Chemical compound C(CCCCCCCCCCCCCCC)[C@@]1(N(C[C@@H](C1)O)C(CCCCCCCCCCCCCCC)=O)C(=O)O NSNRBCFTRWSAAQ-BLPFIKBVSA-N 0.000 claims description 3
- GOVINWHEYOSPAK-GPOMZPHUSA-N hexadecyl (2s,4r)-1-hexadecanoyl-4-hydroxypyrrolidine-2-carboxylate Chemical compound CCCCCCCCCCCCCCCCOC(=O)[C@@H]1C[C@@H](O)CN1C(=O)CCCCCCCCCCCCCCC GOVINWHEYOSPAK-GPOMZPHUSA-N 0.000 claims description 3
- 239000003921 oil Substances 0.000 claims description 3
- 239000001243 zingiber officinale rosc. root absolute Substances 0.000 claims description 3
- SRHSPJGTSWHUTH-MOPGFXCFSA-N (2s,4r)-1-hexadecanoyl-4-hydroxypyrrolidine-2-carboxylic acid Chemical compound CCCCCCCCCCCCCCCC(=O)N1C[C@H](O)C[C@H]1C(O)=O SRHSPJGTSWHUTH-MOPGFXCFSA-N 0.000 abstract description 2
- 241000283153 Cetacea Species 0.000 abstract description 2
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 239000011347 resin Substances 0.000 abstract 1
- 229920005989 resin Polymers 0.000 abstract 1
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 24
- 230000000694 effects Effects 0.000 description 15
- 239000011787 zinc oxide Substances 0.000 description 12
- 210000001217 buttock Anatomy 0.000 description 8
- 206010061218 Inflammation Diseases 0.000 description 7
- 230000000844 anti-bacterial effect Effects 0.000 description 7
- 230000006870 function Effects 0.000 description 6
- 230000004054 inflammatory process Effects 0.000 description 6
- 230000008439 repair process Effects 0.000 description 6
- 230000003110 anti-inflammatory effect Effects 0.000 description 5
- 210000000436 anus Anatomy 0.000 description 4
- 239000002131 composite material Substances 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 229940102465 ginger root Drugs 0.000 description 4
- 230000035876 healing Effects 0.000 description 4
- 238000002955 isolation Methods 0.000 description 4
- 230000008591 skin barrier function Effects 0.000 description 4
- 239000001841 zingiber officinale Substances 0.000 description 4
- 206010012444 Dermatitis diaper Diseases 0.000 description 3
- 208000003105 Diaper Rash Diseases 0.000 description 3
- FDSLJAYOPNMZIY-UXHICEINSA-N N-Hexadecyl-L-hydroxyproline Chemical compound CCCCCCCCCCCCCCCCN1C[C@H](O)C[C@H]1C(O)=O FDSLJAYOPNMZIY-UXHICEINSA-N 0.000 description 3
- 150000001647 brassinosteroids Chemical class 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 230000001681 protective effect Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- 102000015696 Interleukins Human genes 0.000 description 2
- 108010063738 Interleukins Proteins 0.000 description 2
- 240000006831 Rubus chamaemorus Species 0.000 description 2
- 235000016554 Rubus chamaemorus Nutrition 0.000 description 2
- 229930182558 Sterol Natural products 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 208000026935 allergic disease Diseases 0.000 description 2
- 230000007815 allergy Effects 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 239000002085 irritant Substances 0.000 description 2
- 231100000021 irritant Toxicity 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 235000008390 olive oil Nutrition 0.000 description 2
- 239000004006 olive oil Substances 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 210000002374 sebum Anatomy 0.000 description 2
- 150000003432 sterols Chemical class 0.000 description 2
- 235000003702 sterols Nutrition 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 230000029663 wound healing Effects 0.000 description 2
- 239000001500 (2R)-6-methyl-2-[(1R)-4-methyl-1-cyclohex-3-enyl]hept-5-en-2-ol Substances 0.000 description 1
- MTXSIJUGVMTTMU-JTQLQIEISA-N (S)-anabasine Chemical compound N1CCCC[C@H]1C1=CC=CN=C1 MTXSIJUGVMTTMU-JTQLQIEISA-N 0.000 description 1
- 244000298715 Actinidia chinensis Species 0.000 description 1
- 235000009434 Actinidia chinensis Nutrition 0.000 description 1
- 235000009436 Actinidia deliciosa Nutrition 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 238000012404 In vitro experiment Methods 0.000 description 1
- GNOYXKFPMCFZDK-OOLPFSOCSA-N N1[C@H](C(=O)O)C[C@@H](O)C1.C(CCCCCCCCCCCCCCC)(=O)OCCCCCCCCCCCCCCCC Chemical compound N1[C@H](C(=O)O)C[C@@H](O)C1.C(CCCCCCCCCCCCCCC)(=O)OCCCCCCCCCCCCCCCC GNOYXKFPMCFZDK-OOLPFSOCSA-N 0.000 description 1
- 229930194930 Triterpen Natural products 0.000 description 1
- -1 Triterpene ester Chemical class 0.000 description 1
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 1
- 102100040247 Tumor necrosis factor Human genes 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 229930014345 anabasine Natural products 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 235000019606 astringent taste Nutrition 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000037365 barrier function of the epidermis Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 235000021028 berry Nutrition 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 210000003038 endothelium Anatomy 0.000 description 1
- 230000006353 environmental stress Effects 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 238000005562 fading Methods 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 150000002617 leukotrienes Chemical class 0.000 description 1
- 239000004973 liquid crystal related substance Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 230000037307 sensitive skin Effects 0.000 description 1
- 230000008786 sensory perception of smell Effects 0.000 description 1
- 230000005808 skin problem Effects 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 125000003523 triterpene group Chemical group 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 238000011179 visual inspection Methods 0.000 description 1
- RNWHGQJWIACOKP-UHFFFAOYSA-N zinc;oxygen(2-) Chemical compound [O-2].[Zn+2] RNWHGQJWIACOKP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/342—Alcohols having more than seven atoms in an unbroken chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/35—Ketones, e.g. benzophenone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/678—Tocopherol, i.e. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/927—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of insects, e.g. shellac
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/005—Preparations for sensitive skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/48—Thickener, Thickening system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/524—Preservatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
Abstract
The invention relates to an infant buttocks-care cream, which relates to the technical field of skin care products and comprises water, an emulsifier, grease, a thickening stabilizer, antiseptic components and functional components, wherein the emulsifier comprises cetearyl alcohol olive oleate and sorbitan olive oleate, the grease comprises shea butter fruit resin extract, the thickening stabilizer comprises beeswax and xanthan gum, the antiseptic components comprise 1.2 pentanediol and p-hydroxyacetophenone, and the functional components comprise bisabolol, ginger extract, N-palmitoyl hydroxyproline whale wax ester, β -glucan and allantoin.
Description
Technical Field
The invention relates to the technical field of skin care products, in particular to infant hip cream.
Background
The red buttocks of babies are also called diaper rash or diaper rash in medicine. Diaper rash also occurs due to a plurality of factors, such as thin cuticle of skin of a baby, more moisture and chloride in endothelium and easy allergy; the natural sebum protective film of the skin is damaged by stimulation such as frequent milk overflow, urine, paper diaper friction and the like; the hip skin is moist for a long time, the diaper is not breathable when being worn, and a large amount of germs are easy to breed on the surface of the skin when the diaper is used for a long time; the hip skin is often contacted with some cleaning solutions, the original beneficial flora balance of the skin of the baby is broken, and the protective effect of the skin mucosa is damaged due to flora disorder.
In the market, hot-market infant hip cream brands such as Sudocrem UK fart cream, Beijing, ganick, Miaosile, Lu' an-fit products and the like all contain zinc oxide components, and although zinc oxide can effectively prevent water, isolate, astringe the skin and prolong the effective bacteriostasis time, more and more researches show that zinc oxide particles have the characteristics of moisture absorption and astringency, the zinc oxide particles can slightly dehydrate the skin and are not suitable for frequent use; and the effect is that the protective film is formed on the surface of the skin, only the red butt can be relieved, the symptoms and root causes are treated, and the effectiveness is slightly poor.
In addition, because conventional cream emulsions require the addition of conventional preservatives for their shelf life, there is a clear specification in the cosmetic safety specifications (2015 edition) which are acceptable preservatives for cosmetic use, such as: the traditional preservatives can cause more or less potential harm to the skin in the long-term use process of the skin, and some preservatives are gradually forbidden even in the European Union.
In order to improve the safety of the product, the development of baby skin care products with lower irritation, better anti-inflammatory and antibacterial effects and higher safety is needed.
Disclosure of Invention
In view of the above, the technical problem to be solved by the present invention is to provide a baby hip cream, which does not contain zinc oxide substance, does not contain traditional antiseptic, has more natural components, and has better and safer anti-inflammatory and antibacterial effects.
In order to solve the technical problems, the invention adopts the following technical scheme:
a baby hip cream comprises water, emulsifier, oil, thickening stabilizer, antiseptic component, and effective component,
the emulsifier is olive oil emulsifier from Italy B & T company, the olive oil is grease similar to human sebum, the emulsion forms lamellar liquid crystal structure, is easily absorbed by skin, and shows excellent absorbability of active ingredients, and specifically comprises cetearyl olive oleate and sorbitan olive oleate.
The grease adopts vegetable grease, and is specially selected from a shea butter extract with anti-inflammatory and skin repair functions, and is sourced from AAK (American Association of Kiwi berry) manufacturers in the world;
the thickening stabilizer adopts the matching of beeswax and xanthan gum;
the preservative component is prepared by matching 1.2 pentanediol and p-hydroxyacetophenone, is very safe and mild, and has broad-spectrum antibacterial property;
the functional components are reasonable in matching, the inflammation is well inhibited by selecting the matching of bisabolol and ginger root, the skin barrier is reconstructed by selecting cetyl N-palmitoyl hydroxyproline to increase the tolerance of tender skin of a baby, particularly the fragile skin of the anus, β -glucan is selected and extracted from oat and compounded with allantoin, the healing of wounds of the fragile skin of the anus or the hip can be promoted, and the tender skin of the baby is protected in multiple mechanisms.
An infant hip cream comprises the following components in percentage by weight:
1-5% of cetearyl olive oleate (CETEARY L O L IVATE), 1-5% of SORBITAN olive oleate (SORBITAN O L IVATE), 10-20% of shea butter, 0.5-1.5% of shea butter extract, 1-3% of beeswax, 0.1-0.3% of xanthan gum, 2-6% of 1, 2-pentanediol, 0.3-0.8% of p-hydroxyacetophenone, 0.01-0.08% of bisabolol, 0.05-0.15% of ginger extract, 0.1-0.5% of cetyl palmitate hydroxyproline, 0.3-0.8% of β -glucan, 0.1-0.3% of allantoin and the balance of water.
Preferably, the infant hip cream of the present invention comprises the following components by weight:
cetearyl alcohol olive oleate 3%, sorbitan olive oleate 3%, shea butter 16%, shea butter extract 1%, beeswax 2%, xanthan gum 0.2%, 1, 2-pentanediol 4%, p-hydroxyacetophenone 0.5%, bisabolol 0.05%, ginger extract 0.1%, N-palmitoyl hydroxyproline cetyl ester 0.3%, β -dextran 0.5%, allantoin 0.2%, and balance water.
Furthermore, the infant hip cream also comprises 0.3-0.8% of hexyldecanol, 0.05-0.15% of stearic acid and 0.05-0.15% of rape sterol, and the three components form a skin composite repair system.
The ratio of hexyldecanol to stearic acid in the infant hip cream of the present invention is preferably 0.5%, the ratio of stearic acid is preferably 0.1%, and the ratio of campesterol is preferably 0.1%.
Furthermore, the infant hip cream provided by the invention also comprises 0.05-0.15% of tocopherol (vitamin E) which is used as an antioxidant to maintain the stability of vegetable oil.
The content of tocopherol (vitamin E) in the infant hip cream of the present invention is preferably 0.1%.
Further, the ginger extract in the present invention is a ginger root extract.
According to the invention, the beewax and the xanthan gum are matched to serve as a thickening stable combination, the beewax and the xanthan gum have excellent safety performance when used, 1.2 pentanediol and p-hydroxyacetophenone serve as antiseptic volumes, the product is safe and mild, and has broad-spectrum antibacterial properties, the functional components play roles in resisting inflammation, reconstructing a skin barrier and promoting wound healing, the combination of bisabolol and ginger root can well inhibit inflammation, the N-palmitoyl hydroxyproline whale wax ester reconstructs the skin barrier to increase the tolerance of tender skin of a baby, particularly the fragile skin of the anus edge, β -glucan is a component extracted from oat and is compounded with allantoin, the healing of the damaged skin of the anus edge or the hip can be promoted, and the functional components protect the tender skin of the baby in multiple mechanisms.
P-hydroxyacetophenone is a plant source, is particularly mild, is evaluated as the lowest risk of '1' by beauty-repair APP, exists in L ampaya hieronymi (herbal medicine, native to Latin America) and Rubus chamaemorus (cloudberry grown in Gaoshan), has the functions of preventing oxidation, increasing tolerance, stabilizing emulsion and broad preservation, has better water solubility, solves the defect that a plurality of preservatives or preservative substitute products are not easy to add, has the functions of resisting irritation and being a preservative substitute product, is singly used, needs to be added by more than 1 percent to have certain broad spectrum, and has broad-spectrum antibacterial performance at the addition of 0.5 to 0.8 percent if matched with pentanediol.
In the invention, a compound system which replaces zinc oxide and other components with stimulating functions in the traditional hip cream is adopted: shea butter, shea butter extract, repair composite system (N-palmitoyl hydroxyproline cetyl esters, hexyldecanol, stearic acid, brassinosteroids) + xinminshu (bisabolol + ginger root) + allantoin.
1. The shea butter, commonly known as shea butter, is oil extracted from a plant in Africa, has the functions of resisting inflammation, repairing and moistening skin, and has a certain isolation effect;
2. shea butter extract: the shea butter extract with biological activity is in the form of thick and yellow oily gel, contains Triterpene ester (Triterpen), can increase epidermal barrier, protect skin against aging, protect skin against environmental stress, and jointly expresses the functions of repairing skin and resisting inflammation; triterpenes can repair skin problems caused by chemical stress, ultraviolet radiation or municipal pollution;
3. repairing the composite system: the composition of cetyl N-palmitoyl hydroxyproline, hexyldecanol, stearic acid and campesterol can rebuild skin barrier and repair skin, and has anti-inflammatory effect;
4. the material shows that the alpha-bisabolol can reduce the release of leukotriene L TB4 and interleukin 1L-1 a caused by PMA, and simultaneously inhibit the generation of calcium ion mediated interleukin 1L-1 a, but has no inhibiting effect on PGE 2. experiments prove that the ginger root extract can effectively inhibit the synthesis of inflammatory mediator TNF-a, but has no effect on I L-1 a, the two are compounded to form a composite anti-stimulation component with synergistic effect, in vitro experiments prove that the composition has high-efficiency anti-inflammatory and ultraviolet radiation erythema fading effects, and human experiments prove that the composition has synergistic skin anti-stimulation effect;
5.β -dextran + allantoin has effect in promoting wound healing.
The invention can replace zinc oxide by the 5 combinations, and the components are safe and mild from the raw material. Therefore, the zinc oxide can be abandoned from the components of the infant hip cream, and the equivalent effect can still be achieved.
The components of the invention, of which more than 90% are derived from natural sources, include emulsifiers derived from olive extract components; and the safety risk level of all the components is the highest level; the present invention is defined by the FDA and does not identify any risk substances.
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
Example 1
An infant hip cream comprises the following components in percentage by weight:
10% shea butter, 2% 1, 2-pentanediol, 1% cetearyl olive oleate, 1% sorbitan olive oleate, 1% beeswax, 0.5% shea butter extract, 0.3% β -dextran, 0.3% hexyldecanol, 0.01% bisabolol, 0.1% cetyl hydroxyproline N-palmitoyl cetyl wax ester, 0.05% stearic acid, 0.05% brassinosteroids, 0.3% p-hydroxyacetophenone, 0.1% allantoin, 0.1% xanthan gum, 0.05% ginger extract, 0.05% tocopherol, and the balance water.
Example 2
An infant hip cream comprises the following components in percentage by weight:
16% shea butter, 4% 1, 2-pentanediol, 3% cetearyl olive oleate, 3% sorbitan olive oleate, 2% beeswax, 1% shea butter extract, 0.5% β -dextran, 0.5% hexyldecanol, 0.05% bisabolol, 0.3% cetyl hydroxyproline N-palmitoyl cetyl wax ester, 0.1% stearic acid, 0.1% brassinol, 0.5% p-hydroxyacetophenone, 0.2% allantoin, 0.2% xanthan gum, 0.1% ginger extract, 0.1% tocopherol, and the balance water.
Example 3
An infant hip cream comprises the following components in percentage by weight:
20% shea butter, 6% 1, 2-pentanediol, 5% cetearyl olive oleate, 5% sorbitan olive oleate, 3% beeswax, 1.5% shea butter extract, 0.8% β -dextran, 0.8% hexyldecanol, 0.08% bisabolol, 0.5% cetyl hydroxyproline N-palmitoyl cetyl wax ester, 0.15% stearic acid, 0.15% brassinosteroids, 0.8% p-hydroxyacetophenone, 0.3% allantoin, 0.3% xanthan gum, 0.15% ginger extract, 0.15% tocopherol, and the balance water.
The invention is examined for the product of example 2.
The examination method comprises the following steps: the samples were placed in corresponding thermostats, taken out every 30 days, returned to room temperature and examined by smearing, visual inspection, olfaction, sampling and testing, and the results are shown in table 1.
Table 1 product review table of example 2
As can be seen from Table 1, the samples have excellent antibacterial effect, the pH value of the product is stable under the condition of 38-45 ℃ for 90 days, and the color, the smell and the appearance can be kept in good states, which indicates that the hip cream can keep the requirements of the product on no change of the properties for 90 days without the traditional preservative and natural components, and the antibacterial effect is still excellent.
Clinical trial effect
200 red hip children are selected from pediatric wards of children hospitals in Hangzhou city, the children are aged 1-12 months and randomly divided into a control group and an observation group, each group comprises 100 people, wherein each half of the children are male and female, and the children are treated as follows:
(1) the hip cream of example 2 was tested on 100 infants with red buttocks, after each stool, the infants were immediately washed with warm water and wiped dry, and then a layer of hip cream was applied with a sterile cotton swab;
(2) after each defecation, the control group is cleaned by warm water and wiped dry without coating hip cream;
the healing of two groups of red hip infants was counted daily during one week, and the results are shown in table 2.
TABLE 2 healing of two groups of infants with red buttocks in one week
As can be seen from table 2, in the observation group, the cure rate of the hip cream of the present invention can reach 6% on day 1, and as time goes on, the cure rate increases at a rate of more than 10 cases/day from day 3, and reaches 98 cases on day 7, and the cure rate reaches 98%. In the control group, the cure rate was 0 on both day 1 and day 2, and the infant patients who had healed with red buttocks began to appear on the third day, and the cure rate was 38 by day 7. The hip cream has the advantages of obvious effect, quick response, high cure rate and basically response to the skin of a high-sensitivity infant within one week. The compound system of the shea butter, the shea butter extract and the compound repair system (hexyldecanol, stearic acid and campestris sterols), the anabasine (bisabolol, ginger root) and the allantoin can quickly generate an effect on the surface of the skin, can perform the effects of isolation protection, inflammation diminishing and bacteriostasis on the red buttocks, can replace the irritant components such as zinc oxide in the existing hip cream, and can play the effects of quick effect taking and high cure rate under the condition that the components are natural and the traditional preservative is not used.
Product use investigation results
The hip cream of example 2 of the present invention was used on 14 babies as shown in Table 3 below.
TABLE 3 comparison of baby's use of the invention with other brand hip-pads
As can be seen from Table 3, the hip cream provided by the invention can quickly cure red buttocks of babies regardless of sensitive skin with red buttocks or skin with red buttocks not easy to be red, and does not generate reactions such as allergy and the like because the natural components of the product are high and no irritant components such as zinc oxide and the like are contained. Compared with other common hip cream brands, the hip cream does not contain the traditional zinc oxide component, but has excellent absorption and isolation effects and can be satisfied by parents of babies, and the hip cream is a compound system which can replace zinc oxide and has good isolation and anti-inflammation effects.
It should be understood that the above examples are only for clarity of illustration and are not intended to limit the embodiments. Other variations and modifications will be apparent to persons skilled in the art in light of the above description. And are neither required nor exhaustive of all embodiments. And any modifications, equivalents, improvements and the like which are obvious and which are made by this disclosure are intended to be included within the scope of the present invention.
Claims (8)
1. An infant hip cream is characterized by comprising an emulsifier, grease, a thickening stabilizer, an antiseptic component, an effective component and water, wherein,
the emulsifier comprises cetearyl olive oleate and sorbitan olive oleate;
the oil comprises shea butter and shea butter extract;
the thickening stabilizer comprises beeswax and xanthan gum;
the preservative component comprises 1.2 pentanediol and p-hydroxyacetophenone;
the effective components comprise bisabolol, ginger extract, cetyl N-palmitoyl hydroxyproline, β -dextran, and allantoin.
2. The infant hip cream according to claim 1, characterized by comprising the following components in percentage by mass:
1-5% of cetearyl alcohol olive oleate, 1-5% of sorbitan olive oleate, 10-20% of shea butter, 0.5-1.5% of shea butter extract, 1-3% of beeswax, 0.1-0.3% of xanthan gum, 2-6% of 1, 2-pentanediol, 0.3-0.8% of p-hydroxyacetophenone, 0.01-0.08% of bisabolol, 0.05-0.15% of ginger extract, 0.1-0.5% of N-palmitoyl hydroxyproline cetyl wax ester, 0.3-0.8% of β -glucan, 0.1-0.3% of allantoin and the balance of water.
3. The infant hip cream according to claim 2, characterized by comprising the following components in percentage by mass:
cetearyl alcohol olive oleate 3%, sorbitan olive oleate 3%, shea butter 16%, shea butter extract 1%, beeswax 2%, xanthan gum 0.2%, 1, 2-pentanediol 4%, p-hydroxyacetophenone 0.5%, bisabolol 0.05%, ginger extract 0.1%, N-palmitoyl hydroxyproline cetyl ester 0.3%, β -dextran 0.5%, allantoin 0.2%, and balance water.
4. The infant hip cream according to claim 2 or 3, further comprising hexyldecanol 0.3-0.8%, stearic acid 0.05-0.15%, campesterol 0.05-0.15%.
5. The infant hip cream according to claim 4, characterized in that said ratio of hexyldecanol is 0.5%, stearic acid is 0.1%, campesterol is 0.1%.
6. The infant hip cream according to claim 2 or 3, further comprising 0.05-0.15% of tocopherol.
7. The infant hip cream according to claim 6, characterized in that the content of tocopherol is 0.1%.
8. The infant hip cream according to claim 2 or 3, wherein the ginger extract is a ginger root extract.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010404346.3A CN111437234A (en) | 2020-05-13 | 2020-05-13 | Baby hip protection cream |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010404346.3A CN111437234A (en) | 2020-05-13 | 2020-05-13 | Baby hip protection cream |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111437234A true CN111437234A (en) | 2020-07-24 |
Family
ID=71657572
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010404346.3A Pending CN111437234A (en) | 2020-05-13 | 2020-05-13 | Baby hip protection cream |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111437234A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112494377A (en) * | 2020-09-22 | 2021-03-16 | 福建省梦娇兰日用化学品有限公司 | Infant repair cream containing rape-derived phytosterol and preparation method thereof |
CN113057911A (en) * | 2021-04-12 | 2021-07-02 | 杭州易蓬科技有限公司 | Skin care composition with water resistance and antibacterial effect |
CN115581652A (en) * | 2022-02-11 | 2023-01-10 | 上海漫虹生物科技有限公司 | Eczema cream for repairing skin injury and preparation method thereof |
CN115813779A (en) * | 2023-01-09 | 2023-03-21 | 卡莱丽化妆品有限公司 | Self-help temperature-control slow-release hip-protecting cream and preparation method thereof |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105997718A (en) * | 2016-07-08 | 2016-10-12 | 广州科玛生物科技股份有限公司 | Infant hip care cream and preparation method thereof |
US20160317576A1 (en) * | 2014-10-28 | 2016-11-03 | Andrea Rosanoff | Cream transdermal magnesium supplement |
CN107811950A (en) * | 2017-12-06 | 2018-03-20 | 佛山微赢电子商务有限公司 | A kind of stern protection cream to baby's skin with nursing effect and preparation method thereof |
CN110721150A (en) * | 2019-11-29 | 2020-01-24 | 广州环亚化妆品科技有限公司 | Baby hip-protecting cream and preparation method thereof |
-
2020
- 2020-05-13 CN CN202010404346.3A patent/CN111437234A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20160317576A1 (en) * | 2014-10-28 | 2016-11-03 | Andrea Rosanoff | Cream transdermal magnesium supplement |
CN105997718A (en) * | 2016-07-08 | 2016-10-12 | 广州科玛生物科技股份有限公司 | Infant hip care cream and preparation method thereof |
CN107811950A (en) * | 2017-12-06 | 2018-03-20 | 佛山微赢电子商务有限公司 | A kind of stern protection cream to baby's skin with nursing effect and preparation method thereof |
CN110721150A (en) * | 2019-11-29 | 2020-01-24 | 广州环亚化妆品科技有限公司 | Baby hip-protecting cream and preparation method thereof |
Non-Patent Citations (1)
Title |
---|
吉林省盛世婴才母婴用品有限责任公司: "《国产普通化妆品备案信息》", 6 May 2017 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112494377A (en) * | 2020-09-22 | 2021-03-16 | 福建省梦娇兰日用化学品有限公司 | Infant repair cream containing rape-derived phytosterol and preparation method thereof |
CN113057911A (en) * | 2021-04-12 | 2021-07-02 | 杭州易蓬科技有限公司 | Skin care composition with water resistance and antibacterial effect |
CN115581652A (en) * | 2022-02-11 | 2023-01-10 | 上海漫虹生物科技有限公司 | Eczema cream for repairing skin injury and preparation method thereof |
CN115813779A (en) * | 2023-01-09 | 2023-03-21 | 卡莱丽化妆品有限公司 | Self-help temperature-control slow-release hip-protecting cream and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11571373B2 (en) | Skin care preparations for babies | |
CN111437234A (en) | Baby hip protection cream | |
CN109044915B (en) | Infant hip-protecting cream and preparation process thereof | |
CN109481386A (en) | A kind of infant's multiple-effect nursing creams and preparation method thereof | |
CN105853260B (en) | A kind of diaper dermatitis frost and preparation method thereof | |
WO2002007745A1 (en) | Antipruritic compositions and compositions promoting wound healing | |
CN105816848A (en) | Protective cream capable of dispelling dampness and preparation method thereof | |
CN109331095A (en) | A kind of clearing damp rash composition and preparation method thereof | |
CN111329885B (en) | Pharmaceutical composition and cosmetic composition for improving or preventing symptoms of high altitude red, preparation method of pharmaceutical composition and cosmetic | |
CN111374924A (en) | Baby wheat fresh extract raw pulp hip-protecting cream and preparation method thereof | |
CN109260054B (en) | Plant anti-mosquito itching-relieving cream and preparation method thereof | |
CN109953923A (en) | A kind of hair eyelashes growth-promoting media containing schizophyllan, Radix Rehmanniae and pine extract | |
WO2024045952A1 (en) | Recombinant collagen-containing composition having effects of repairing and soothing, eye cream containing same, preparation method therefor, and use thereof | |
CN110302121B (en) | Infant hip-protecting cream containing plant essence and preparation method thereof | |
CN107496977B (en) | Liquid dressing prepared from pure natural plant extract and preparation method thereof | |
KR102443283B1 (en) | Cosmetic composition with excellent skin barrier using skin microbiome | |
CN111228154A (en) | Fresh wheat extract protoplasm milk for infants and preparation method thereof | |
CN115770209A (en) | Rod-shaped lithospermum ointment containing three-purple oil and preparation method thereof | |
KR20150106244A (en) | UV protection and moisturizing cosmetic composition | |
CN107115383B (en) | Skin care/treatment composition having skin xerosis syndrome preventing and treating effect | |
KR101326679B1 (en) | Skin external composition for treating or alleviating diaper rash containing zinc oxide stabilized by polyglyceryl-2 dipolyhydroxystearate | |
KR102641072B1 (en) | Lip balm composition and lip balm prepared including the same | |
CN112754974B (en) | Composition with anti-allergy repairing effect and preparation method thereof | |
CN116327620B (en) | Calendula skin care oil for infants and preparation method thereof | |
AU2013254342B2 (en) | New compositions for the treatment of chronic ulcers |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200724 |
|
RJ01 | Rejection of invention patent application after publication |